BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7432502)

  • 1. Ca2+-calmodulin-dependent phosphorylation and platelet secretion.
    Nishikawa M; Tanaka T; Hidaka H
    Nature; 1980 Oct; 287(5785):863-5. PubMed ID: 7432502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
    Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
    Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.
    Nishikawa M; Hidaka H
    J Clin Invest; 1982 Jun; 69(6):1348-55. PubMed ID: 7085878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester-induced activation of human platelets is associated with protein kinase C phosphorylation of myosin light chains.
    Naka M; Nishikawa M; Adelstein RS; Hidaka H
    Nature; 1983 Dec 1-7; 306(5942):490-2. PubMed ID: 6689054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of calcium accumulation and efflux from platelet vesicles. Possible role for cyclic-AMP-dependent phosphorylation and calmodulin.
    Le Peuch CJ; Le Peuch DA; Katz S; Demaille JG; Hincke MT; Bredoux R; Enouf J; Levy-Toledano S; Caen J
    Biochim Biophys Acta; 1983 Jun; 731(3):456-64. PubMed ID: 6134552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of non-muscle myosin assembly by calmodulin-dependent light chain kinase.
    Scholey JM; Taylor KA; Kendrick-Jones J
    Nature; 1980 Sep; 287(5779):233-5. PubMed ID: 6893621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin secretion from human platelets may be modified by Ca2+-activated, phospholipid-dependent myosin phosphorylation.
    Inagaki M; Kawamoto S; Hidaka H
    J Biol Chem; 1984 Dec; 259(23):14321-3. PubMed ID: 6238960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity.
    Hathaway DR; Adelstein RS
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1653-7. PubMed ID: 156362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+, calmodulin and cyclic AMP-dependent modulation of actin-myosin interactions in aorta.
    Silver PJ; Holroyde MJ; Solaro RJ; Disalvo J
    Biochim Biophys Acta; 1981 Apr; 674(1):65-70. PubMed ID: 6263347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-dependent contraction of human lung fibroblasts treated with Triton X-100: a role of Ca2+-calmodulin-dependent phosphorylation of myosin 20,000-dalton light chain.
    Masuda H; Owaribe K; Hayashi H; Hatano S
    Cell Motil; 1984; 4(5):315-31. PubMed ID: 6334557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.
    Silver PJ; Ambrose JM; Michalak RJ; Dachiw J
    Eur J Pharmacol; 1984 Jul; 102(3-4):417-24. PubMed ID: 6489434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phosphorylation of smooth-muscle caldesmon.
    Ngai PK; Walsh MP
    Biochem J; 1987 Jun; 244(2):417-25. PubMed ID: 2822003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of smooth muscle contractile proteins by calmodulin and cyclic AMP.
    Adelstein RS; Sellers JR; Conti MA; Pato MD; de Lanerolle P
    Fed Proc; 1982 Oct; 41(12):2873-8. PubMed ID: 6290274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gizzard Ca2+-independent myosin light chain kinase: evidence in favor of the phosphorylation theory.
    Walsh MP; Bridenbaugh R; Kerrick WG; Hartshorne DJ
    Fed Proc; 1983 Jan; 42(1):45-50. PubMed ID: 6848377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormones inhibit platelet function and myosin light chain kinase.
    Mamiya S; Hagiwara M; Inoue S; Hidaka H
    J Biol Chem; 1989 May; 264(15):8575-9. PubMed ID: 2722789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet calmodulin-binding proteins: identification and Ca2+-dependent proteolysis upon platelet activation.
    Wallace RW; Tallant EA; McManus MC
    Biochemistry; 1987 May; 26(10):2766-73. PubMed ID: 3111525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphosphorylation of platelet myosin by myosin light chain kinase.
    Itoh K; Hara T; Shibata N
    Biochim Biophys Acta; 1992 Feb; 1133(3):286-92. PubMed ID: 1531301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.
    Kanamori M; Naka M; Asano M; Hidaka H
    J Pharmacol Exp Ther; 1981 May; 217(2):494-9. PubMed ID: 6453220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.